Biology-guided adaptive radiation therapy – presence or future?

References

• Overgaard J. Management of the axilla in breast cancer. Implication for diagnosis, prognosis, treatment, and morbidity. Acta Oncol 2000;39:259–60.
   PubMed Web of Science ®Google Scholar
• Levitt S. Second Acta Oncologica symposium on prostate cancer controversies. Acta Oncol 2005;44:526–8.
   PubMed Web of Science ®Google Scholar
• Grau C, Høyer M, Lindegaard J, Overgaard J. The emerging evidence for Stereotactic Body Radiotherapy. Acta Oncol 2006;45: 771–4.
   PubMed Web of Science ®Google Scholar
• Høyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J, Nellemann H, . Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006; 45:823–30.
   PubMed Web of Science ®Google Scholar
• Paludan M, Traberg Hansen A, Petersen J, Grau C, Høyer M. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? Acta Oncol 2006;45: 818–22.
   PubMed Web of Science ®Google Scholar
• Baumann P, Nyman J, Lax I, Friesland S, Høyer M, Rehn Ericsson S, . Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006;45:787–95.
   PubMed Web of Science ®Google Scholar
• Nord C, Ganz PA, Aziz N, Fosså SD. Follow-up of longterm cancer survivors in the Nordic countries. Acta Oncol 2007;46: 433–40.
   PubMed Web of Science ®Google Scholar
• Aziz NM. Cancer survivorship research: State of knowledge, challenges and opportunities. Acta Oncol 2007;46:417–32.
   PubMed Web of Science ®Google Scholar
• Overgaard J. DBCG: The Danish Breast Cancer Cooperative Group – a 30-year struggle for better breast cancer treatment in Denmark. Acta Oncol 2008;47:491–6.
   PubMed Web of Science ®Google Scholar
• Grau C, Muren LP, Høyer M, Lindegaard JC, Overgaard J. Image-guided adaptive radiotherapy – integration of biology and technology to improve clinical outcome. Acta Oncol 2008;47:1182–5.
   PubMed Web of Science ®Google Scholar
• Nielsen T, Mouridsen K, Maxwell RJ, Stødkilde-Jørgensen H, Østergaard L, Horsman MR. Segmentation of dynamic contrast enhanced magnetic resonance imaging data. Acta Oncol 2008;47:1265–70.
   PubMed Web of Science ®Google Scholar
• Østergaard Noe K, De Senneville B, Elstrøm U, Tanderup K, Sørensen TS. Acceleration and validation of optical flow based deformable registration for image-guided radiotherapy. Acta Oncol 2008;47:1286–93.
   PubMed Web of Science ®Google Scholar
• Pötter R, Kirisits C, Fidarova EF, Dimopoulos JCA, Berger D, Tanderup K, . Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008;47:1325–36.
   PubMed Web of Science ®Google Scholar
• Wright P, Redpath A, Høyer M, Grau C, Muren LP. The normal tissue sparing potential of adaptive strategies in radiotherapy of bladder cancer. Acta Oncol 2008;47: 1382–9.
   PubMed Web of Science ®Google Scholar
• Muren LP, Petersen JB, Hansen J, Hafslund R. Medical physics in the Nordic countries: The past, the present and the future. Acta Oncol 2009;48:165–8.
   PubMed Web of Science ®Google Scholar
• Webb S. The contribution, history, impact and future of physics in medicine. Acta Oncol 2009;48:169–77.
   PubMed Web of Science ®Google Scholar
• Jeraj R. Future of physics in medicine and biology. Acta Oncol 2009;48:178–84.
   PubMed Web of Science ®Google Scholar
• Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren LP. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy. Acta Oncol 2009;48: 238–44.
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Alsner J. Genetic variants and normal tissue toxicity after radiotherapy: A systematic review. Radiother Oncol 2009;92:299–309.
   PubMed Web of Science ®Google Scholar
• Ishkanian AS, Zafarana G, Thoms J, Bristow RG. Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer. Acta Oncol 2010;49:888–94.
   PubMed Web of Science ®Google Scholar
• Busk M, Horsman MR, Overgaard J. Resolution in PET hypoxia imaging: Voxel size matters. Acta Oncol 2008;47: 1201–10.
   PubMed Web of Science ®Google Scholar
• Brock KK, Hawkins M, Eccles C, Moseley JL, Moseley DJ, Jaffray DA, . Improving image-guided target localization through deformable registration. Acta Oncol 2008;47: 1279–85.
   PubMed Web of Science ®Google Scholar
• Newbold KL, Partridge M, Cook G, Sharma B, Rhys-Evans P, Harrington KJ, . Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer. Acta Oncol 2008; 47:1229–36.
   PubMed Web of Science ®Google Scholar
• Roels S, Slagmolen P, Nuyts J, Lee JA, Loeckx D, Maes F, . Biological image-guided radiotherapy in rectal cancer: Is there a role for FMISO or FLT, next to FDG?. Acta Oncol 2008;47:1237–48.
   PubMed Web of Science ®Google Scholar
• Busk M, Munk OL, Jakobsen S, Wang T, Skals M, Steiniche T, . Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET. Acta Oncol 2010;49:922–33.
   PubMed Web of Science ®Google Scholar
• Røe K, Aleksandersen TB, Kristian A, Nilsen LB, Seierstad T, Qu H, . Preclinical dynamic 18F-FDG PET – tumor characterization and radiotherapy response assessment by kinetic compartment analysis. Acta Oncol 2010;49: 914–21.
   PubMed Web of Science ®Google Scholar
• Nielsen T, Murata R, Maxwell RJ, Stødkilde-Jørgensen H, Østergaard L, Ley CD, . Non-invasive imaging of combretastatin activity in two tumour models: Association with invasive estimates. Acta Oncol 2010;49:906–13.
   PubMed Web of Science ®Google Scholar
• Søvik Å, Kippenes Skogmo H, Bruland S, Olsen DR, Malinen E. DCEMRI monitoring of canine tumors during fractionated radiotherapy. Acta Oncol 2008;47:1249–56.
   PubMed Web of Science ®Google Scholar
• Haack S, Morre-Pedersen E, Jespersen SN, Kallehauge JF, Lindegaard JC, Tanderup K. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer. Acta Oncol 2010;49:978–83.
   PubMed Web of Science ®Google Scholar
• Kallehauge JF, Tanderup K, Haack S, Nielsen T, Fokdal L, Lindegaard JC, . Apparent diffusion coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used. Acta Oncol 2010;49:1017–22.
   PubMed Web of Science ®Google Scholar
• Van Herk M. Will IGRT live up to its promise? Acta Oncol 2008;47:1186–7.
   PubMed Web of Science ®Google Scholar
• Verellen D, De Ridder M, Tournel K, Duchateau M, Reynders T, Gevaert T, . An overview of volumetric imaging technologies and their quality assurance for IGRT. Acta Oncol 2008;47:1271–8.
   PubMed Web of Science ®Google Scholar
• Baumann M, Hölscher T, Zips D. The future of IGRT – Cost benefit analysis. Acta Oncol 2008;47:1188–92.
   PubMed Web of Science ®Google Scholar
• Vestergaard A, Søndergaard J, Petersen JB, Høyer M, Muren LP. A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer. Acta Oncol 2010;49:1069–76.
   PubMed Web of Science ®Google Scholar
• Gottlieb KL, Hansen CR, Hansen O, Westberg J, Brink C. Investigation of respiration induced intra- and inter-fractional tumour motion using a standard Cone Beam CT. Acta Oncol 2010;49:1192–8.
   PubMed Web of Science ®Google Scholar
• Elstrøm UV, Wysocka BA, Muren LP, Petersen JB, Grau C. Daily KV cone-beam CT and deformable image registration as a method for studying dosimetric consequences of anatomic changes in adaptive IMRT of head and neck cancer. Acta Oncol 2010;49:1101–8.
   PubMed Web of Science ®Google Scholar
• Røthe Arnesen M, Eilertsen K, Malinen E. Optimal treatment margins for radiotherapy of prostate cancer based on interfraction imaging. Acta Oncol 2008;47:1373–81.
   PubMed Web of Science ®Google Scholar
• Bedford JL, Hansen VN, McNair HA, Aitken AH, Brock JEC, Warrington AP, . Treatment of lung cancer using volumetric modulated arc therapy and image guidance: A case study. Acta Oncol 2008;47:1438–43.
   PubMed Web of Science ®Google Scholar
• Korreman S, Medin J, Kjær-Kristoffersen F. Dosimetric verification of RapidArc treatment delivery. Acta Oncol 2009;48:185–91.
   PubMed Web of Science ®Google Scholar
• Kjær-Kristoffersen F, Ohlhues L, Medin J, Korreman S. RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta Oncol 2009;48:227–32.
   PubMed Web of Science ®Google Scholar
• Deveau M, Bowen SR, Westerly DC, Jeraj R. Feasibility and sensitivity study of helical tomotherapy for dose painting plans. Acta Oncol 2010;49:991–6.
   PubMed Web of Science ®Google Scholar
• William Gibson, in NPR Talk of the Nation (30 November 1999).
   Google Scholar